A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

This study has been completed.
Sponsor:
Collaborator:
The Hong Kong Research Grants Council (RGC)
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT00563199
First received: November 21, 2007
Last updated: June 14, 2011
Last verified: June 2011
  Purpose

This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use. Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.


Condition Intervention
Smoking Cessation
Smoking
Behavioral: nurse-delivered stage-matched smoking cessation counseling

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Official Title: A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Resource links provided by NLM:


Further study details as provided by Hospital Authority, Hong Kong:

Primary Outcome Measures:
  • Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokers [ Time Frame: continuous abstinence for one month at the time of 3, 6 and 12 month follow up ]

Secondary Outcome Measures:
  • Reduction of the number of cigarettes smoked [ Time Frame: at the time of 3, 6 and 12 month follow up ]
  • Progression to a higher stage of readiness to quit [ Time Frame: at the time of 3, 6 and 12 month follow up ]

Estimated Enrollment: 1824
Study Start Date: March 2002
Study Completion Date: December 2005
  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization.
  • Patient speaks and reads Cantonese/Chinese

Exclusion Criteria:

  • Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention.
  • Patient who does not speak or read Chinese
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00563199

Locations
China
Queen Mary Hospital
Hong Kong, China
Pamela Youde Nethersole Eastern Hospital
Hong Kong, China
Princess Margaret Hospital
Hong Kong, China
Queen Elizabeth Hospital
Hong Kong, China
United Christian Hospital
Hong Kong, China
Ruttonjee Hospital / Tang Shiu Kin Hospital
Hong Kong, China
Tseung Kwan O Hospital
Hong Kong, China
Tuen Mun Hospital
Hong Kong, China
Tung Wah Hospital
Hong Kong, China
Caritas Medical Centre
Hong Kong, China
Sponsors and Collaborators
Hospital Authority, Hong Kong
The Hong Kong Research Grants Council (RGC)
Investigators
Principal Investigator: Sophia SC Chan, Dr Department of Nursing Studies, The University of Hong Kong
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00563199     History of Changes
Other Study ID Numbers: NTWC/CREC/325/04, HARECCTR0500022, HKU 7224/01M
Study First Received: November 21, 2007
Last Updated: June 14, 2011
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Hospital Authority, Hong Kong:
smoking cessation
smoking behaviors

ClinicalTrials.gov processed this record on October 21, 2014